Pigmented Villonodular Synovitis

Pigmented villonodular synovitis is a usually noncancerous growth of the synovium, the thin lining inside a joint. The lining becomes thickened and may form nodules or folds; iron-containing blood products called hemosiderin can give the tissue a brown or pigmented appearance. It most often affects one large joint, such as the knee or hip, although other joints and tendon sheaths can be involved. The condition is commonly discussed under the broader term tenosynovial giant cell tumor, or TGCT.

Symptoms can develop gradually, come and go, or return after treatment. The symptoms of pigmented villonodular synovitis may vary depending on whether the disease is localized or diffuse and which joint is affected.

The exact cause of pigmented villonodular synovitis is not fully established. Abnormal overgrowth of cells in the synovial lining appears to play a central role, while repeated microscopic bleeding can leave hemosiderin, an iron-containing blood product, in the tissue. This combination contributes to the thickened, nodular, and pigmented appearance sometimes called villonodular synovitis.

There is no established lifestyle-based prevention target, inherited pattern, or consistently proven modifiable risk factor for pigmented synovitis. The condition can occur in someone who has no identifiable risk factor, so its development is not usually something a person could have prevented through diet, exercise, or routine activity.

Diffuse disease is more likely to involve extensive joint tissue and may be harder to remove completely, which increases the chance of recurrence. Rare malignant transformation has been reported, but it is exceptionally uncommon and is not the expected course of pigmented villonodular synovitis.

Diagnosis begins with a medical history and physical examination. A clinician may ask about recurrent swelling, pain, stiffness, previous injuries, and episodes that could suggest bleeding into the joint. The examination checks tenderness, warmth, swelling, and range of motion, while also looking for a lump or other signs of joint involvement.

Why MRI Is Important

MRI is especially useful in pigmented villonodular synovitis because it can show thickened synovium and signal changes related to hemosiderin. It can also show whether nearby structures are involved and whether the disease appears localized or diffuse. Plain radiographs may identify bone or joint changes, while ultrasound or other imaging may be useful in selected situations. If the diagnosis remains uncertain, a biopsy or examination of tissue removed during surgery may confirm the diagnosis.

Pigmented villonodular synovitis treatment is chosen according to the location of the abnormal tissue, whether disease is localized or diffuse, symptom severity, existing joint damage, and the risk of recurrence. Surgery is often the main treatment, but specialist-directed medicines, radiation-based treatment, or observation may be considered in selected situations.

Synovectomy

A synovectomy removes abnormal synovial tissue from the joint. It is often performed arthroscopically through small incisions when the disease can be reached this way, while open surgery may be needed for extensive or difficult-to-access diffuse disease. Synovectomy is commonly considered when symptoms are significant or the tissue threatens joint function. Recovery includes a gradual return to activity and physical therapy to restore strength, flexibility, and movement.

Nonsurgical Management and Observation

When surgery is unsuitable, incomplete, or followed by recurrence, a specialist may consider targeted medication or radiation-based treatment in selected cases. Carefully selected people with mild or asymptomatic disease may instead be monitored with observation and follow-up examinations or imaging. These choices require individualized care from an orthopedic or other specialist familiar with TGCT and its treatment.

Many people improve after the abnormal synovium is removed or controlled. Localized disease is often easier to treat, while diffuse disease can involve more of the joint, be harder to remove completely, and have a greater chance of recurrence.

The outlook depends on disease extent, existing cartilage or bone damage, how completely the abnormal tissue can be treated, and whether it returns. Physical therapy can support recovery after treatment, while follow-up imaging or examinations help detect recurrence and monitor joint health. These factors are central to understanding the prognosis of pigmented villonodular synovitis.

Arrange a medical evaluation for unexplained or recurring joint swelling, persistent pain or stiffness, reduced movement, warmth, or a lump near a joint. This is especially important when symptoms do not resolve or repeatedly affect the knee, hip, or another large joint, since conditions such as PVNS synovitis may need imaging and specialist assessment.